axicabtagene ciloleucel
daiichi sankyo,gilead sciences
['cart,(-cartitude)', 'lymphoma', 'axi-cel']
study presented at #asco22 shows survival outcomes are similar regardless of race or ethnicity among patients with #lymphoma treated with axi-cel #cartcell therapy read more: #onctwitter
The content you need, when you need it.